Insmed Inc. buy Truist Financial Co.
Start price
20.12.25
/
50%
€148.00
Target price
20.12.26
-
Performance (%)
-16.04%
Price
16.04.26
€124.26
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -16.04%. This prediction currently runs until 20.12.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -8.632% | -8.632% |
| iShares Core DAX® | 0.789% | 1.975% |
| iShares Nasdaq 100 | 4.226% | 4.344% |
| iShares Nikkei 225® | 3.285% | 6.991% |
| iShares S&P 500 | 2.496% | 2.759% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.
Ratings data for INSM provided by MarketBeat